Gregory M. Glenn
2014
In 2014, Gregory M. Glenn earned a total compensation of $1M as President, Research and Development at Novavax.
Compensation breakdown
| Non-Equity Incentive Plan | $165,073 |
|---|---|
| Option Awards | $443,485 |
| Salary | $389,783 |
| Other | $9,920 |
| Total | $1,008,261 |
Glenn received $443.5K in option awards, accounting for 44% of the total pay in 2014.
Glenn also received $165.1K in non-equity incentive plan, $389.8K in salary and $9.9K in other compensation.
Rankings
In 2014, Gregory M. Glenn's compensation ranked 7,572nd out of 13,032 executives tracked by ExecPay. In other words, Glenn earned more than 41.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,572 out of 13,032 | 42nd |
Division Manufacturing | 2,800 out of 4,966 | 44th |
Major group Chemicals And Allied Products | 949 out of 1,686 | 44th |
Industry group Drugs | 746 out of 1,365 | 45th |
Industry Biological Products, Except Diagnostic Substances | 132 out of 236 | 44th |
Source: SEC filing on April 28, 2017.
Glenn's colleagues
We found four more compensation records of executives who worked with Gregory M. Glenn at Novavax in 2014.